Propranolol Safety in Bundle Branch Block

Clinical Context and Safety Profile

The American College of Cardiology recommends that isolated bundle branch block (RBBB or LBBB) with normal AV conduction does not contraindicate beta-blocker therapy, as stated in the ACC/AHA perioperative guidelines 1
In patients with dilated cardiomyopathy and bundle branch block, beta-blockers are recommended as optimal medical therapy to reduce the risk of sudden death and progressive heart failure, according to the European Heart Journal 2
Exercise extreme caution when using propranolol in patients with bifascicular block with syncope, as the mechanism may be intermittent complete heart block rather than a rhythm amenable to beta-blockade, as noted in Circulation 3 and the European Heart Journal 4
Propranolol should be avoided in patients with sick sinus syndrome or symptomatic bradycardia in addition to bundle branch block, as beta-blockers can precipitate severe bradycardia, according to the Journal of the American College of Cardiology 5
The presence of alternating bundle branch block indicates unstable trifascicular disease with high risk of complete heart block, and these patients require pacing, with beta-blockers to be used with extreme caution, as stated in Circulation 3

If isolated RBBB or LBBB with normal PR interval and no symptoms of bradycardia, propranolol is safe, as recommended by the American College of Cardiology 1
If bifascicular block with syncope, an electrophysiology study should be obtained before initiating propranolol, as syncope may indicate intermittent complete heart block, according to Circulation 3
In structural heart disease with bundle branch block, beta-blockers are often beneficial and recommended, such as in dilated cardiomyopathy or heart failure, as noted in the European Heart Journal 2

The American College of Cardiology advises against confusing bundle branch block with AV block, as propranolol primarily affects AV nodal conduction, not bundle branch conduction 5
The European Heart Journal recommends not withholding beta-blockers in heart failure patients with bundle branch block, as these patients benefit significantly from beta-blocker therapy for mortality reduction 2
The Journal of the American College of Cardiology suggests not assuming all syncope in bundle branch block patients is vasovagal, as beta-blockers have shown limited efficacy for vasovagal syncope and may worsen outcomes if the true mechanism is intermittent complete heart block 7, 8, 9